Neuberger Berman Group LLC Innoviva, Inc. Transaction History

Neuberger Berman Group LLC

  • $118 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$11.45 - $13.96 $647,039 - $788,879
-56,510 Closed
0 $0
Q4 2020

Feb 10, 2021
SELL
$9.33 - $12.48 $233 - $312
-25 Reduced 0.04%
56,510 $700,000
Q2 2020

Aug 13, 2020
BUY
$11.49 - $15.26 $649,587 - $862,724
56,535 New
56,535 $790,000

Others Institutions Holding INVA

# of Institutions
222
Shares Held
79.7M
Call Options Held
20K
Put Options Held
5.4K
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.35B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email